TYFEGRA Trademark

Trademark Overview

On Wednesday, December 10, 2014, a trademark application was filed for TYFEGRA with the United States Patent and Trademark Office. The USPTO has given the TYFEGRA trademark a serial number of 86476758. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, January 6, 2023. This trademark is owned by AstraZeneca AB. The TYFEGRA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for use in oncology; Pharmaceutical preparations and substances for the treatment of cardiovascular diseases and disorders, metabolic diseases and disorders, respiratory diseases and disorders, gastrointestinal diseases and disorders, nervous system diseases and disorders, infection and inflammation
tyfegra

General Information

Serial Number86476758
Word MarkTYFEGRA
Filing DateWednesday, December 10, 2014
Status710 - CANCELLED - SECTION 8
Status DateFriday, January 6, 2023
Registration Number4980727
Registration DateTuesday, June 21, 2016
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 8, 2015

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for use in oncology; Pharmaceutical preparations and substances for the treatment of cardiovascular diseases and disorders, metabolic diseases and disorders, respiratory diseases and disorders, gastrointestinal diseases and disorders, nervous system diseases and disorders, infection and inflammation

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, January 6, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAstraZeneca AB
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSödertälje SE-15185
SE
Party NameAstraZeneca AB
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSödertälje SE-15185
SE
Party NameAstraZeneca AB
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSödertälje SE-15185
SE

Trademark Events

Event DateEvent Description
Friday, January 6, 2023CANCELLED SEC. 8 (6-YR)
Thursday, July 22, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, July 22, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, July 22, 2021TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Thursday, July 22, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, July 22, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, July 22, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, June 21, 2021COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, June 21, 2016REGISTERED-PRINCIPAL REGISTER
Wednesday, May 18, 20161(B) BASIS DELETED; PROCEED TO REGISTRATION
Wednesday, March 30, 2016NOTICE OF ALLOWANCE CANCELLED
Monday, May 16, 2016CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, March 30, 2016TEAS DELETE 1(B) BASIS RECEIVED
Tuesday, November 3, 2015NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, September 8, 2015OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 8, 2015PUBLISHED FOR OPPOSITION
Wednesday, August 19, 2015NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, August 5, 2015LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, July 28, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, July 23, 2015TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, July 23, 2015CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, July 16, 2015ASSIGNED TO LIE
Wednesday, July 8, 2015TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, February 19, 2015NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, February 19, 2015NON-FINAL ACTION E-MAILED
Thursday, February 19, 2015NON-FINAL ACTION WRITTEN
Saturday, February 14, 2015ASSIGNED TO EXAMINER
Monday, December 15, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, December 13, 2014NEW APPLICATION ENTERED

Related Keywords

tyfegra diseases disorders substances preparations pharmaceutical nervous system inflammation infection gastrointestinal